Polyanhydride Nanovaccine Induces Robust Pulmonary B and T Cell Immunity and Confers Protection Against Homologous and Heterologous Influenza A Virus Infections

Influenza A virus (IAV) is a major cause of respiratory illness. Given the disease severity, associated economic costs, and recent appearance of novel IAV strains, there is a renewed interest in developing novel and efficacious “universal” IAV vaccination strategies. Recent studies have highlighted...

Descripción completa

Detalles Bibliográficos
Autores principales: Zacharias, Zeb R., Ross, Kathleen A., Hornick, Emma E., Goodman, Jonathan T., Narasimhan, Balaji, Waldschmidt, Thomas J., Legge, Kevin L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127617/
https://www.ncbi.nlm.nih.gov/pubmed/30233573
http://dx.doi.org/10.3389/fimmu.2018.01953

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127617/
https://www.ncbi.nlm.nih.gov/pubmed/30233573
http://dx.doi.org/10.3389/fimmu.2018.01953

Ejemplares similares